Progress in the study of parvovirus entry pathway.


Journal

Virology journal
ISSN: 1743-422X
Titre abrégé: Virol J
Pays: England
ID NLM: 101231645

Informations de publication

Date de publication:
04 04 2023
Historique:
received: 27 12 2022
accepted: 21 03 2023
medline: 6 4 2023
entrez: 4 4 2023
pubmed: 5 4 2023
Statut: epublish

Résumé

A group of DNA viruses called parvoviruses that have significant effects on cancer therapy and genetic engineering applications. After passing through the cell membrane to reach the cytosol, it moves along the microtubule toward the nuclear membrane. The nuclear localization signal (NLS) is recognized by importin-beta (impβ) and other proteins from the complex outside the nuclear membrane and binds to enter the nucleus via the nuclear pore complex (NPC). There are two main pathways for viruses to enter the nucleus. The classical pathway is through the interaction of imp α and impβ with NLS via NPC. The other is the NPC mediated by the combination of impβ and it. While the capsid is introduced into the nucleus through classical nuclear transduction, there is also a transient nuclear membrane dissolution leading to passive transport into the nucleus, which has been proposed in recent years. This article mainly discusses several nuclear entry pathways and related proteins, providing a reference for subsequent research on viral entry pathways.

Identifiants

pubmed: 37016419
doi: 10.1186/s12985-023-02016-z
pii: 10.1186/s12985-023-02016-z
pmc: PMC10072039
doi:

Substances chimiques

Nuclear Localization Signals 0
beta Karyopherins 0
alpha Karyopherins 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

61

Informations de copyright

© 2023. The Author(s).

Références

J Virol. 2003 Oct;77(19):10270-9
pubmed: 12970411
FEBS Lett. 2020 Jun;594(12):1838-1847
pubmed: 32215924
Virol J. 2015 Jan 29;12:6
pubmed: 25630937
J Cell Biol. 2016 Oct 10;215(1):57-76
pubmed: 27697925
Science. 1991 Mar 22;251(5000):1456-64
pubmed: 2006420
Mol Microbiol. 2022 Oct;118(4):295-308
pubmed: 35974704
J Virol. 2020 Jan 31;94(4):
pubmed: 31748386
Development. 2019 Mar 15;146(6):
pubmed: 30877125
Oncogene. 2020 Jan;39(2):454-468
pubmed: 31492900
Immunol Rev. 2015 Nov;268(1):340-64
pubmed: 26497532
Microbiol Mol Biol Rev. 2001 Dec;65(4):570-94, table of contents
pubmed: 11729264
FEBS Lett. 1997 Dec 15;419(2-3):249-54
pubmed: 9428644
Sci Rep. 2018 Jan 18;8(1):1152
pubmed: 29348472
Ann Diagn Pathol. 2018 Jun;34:36-41
pubmed: 29661725
Virology. 2007 Oct 10;367(1):10-8
pubmed: 17588632
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1717-22
pubmed: 12563037
Curr Opin Struct Biol. 2006 Apr;16(2):237-44
pubmed: 16567089
J Biol Chem. 2003 Jun 13;278(24):21361-9
pubmed: 12672802
J Mol Biol. 2001 May 25;309(1):1-18
pubmed: 11491282
Science. 2005 Jun 3;308(5727):1469-72
pubmed: 15817813
J Gen Virol. 1988 May;69 ( Pt 5):1111-6
pubmed: 2836554
J Exp Bot. 2021 Sep 30;72(18):6140-6149
pubmed: 34089597
Mol Cell Proteomics. 2008 Jul;7(7):1254-69
pubmed: 18353765
Trends Biochem Sci. 2002 Dec;27(12):593-6
pubmed: 12468221
J Infect. 2003 Oct;47(3):236-42
pubmed: 12963386
J Virol. 2012 Oct;86(19):10462-73
pubmed: 22811523
EMBO J. 2013 Dec 11;32(24):3220-30
pubmed: 24213245
Viruses. 2021 Jul 05;13(7):
pubmed: 34372512
Nat Rev Genet. 2009 Jan;10(1):57-63
pubmed: 19015660
Nat Methods. 2013 Dec;10(12):1213-8
pubmed: 24097267
Virology. 2003 Nov 25;316(2):267-80
pubmed: 14644609
Medicina (Kaunas). 2022 May 15;58(5):
pubmed: 35630081
J Cell Sci. 2009 Mar 1;122(Pt 5):587-93
pubmed: 19225125
EMBO J. 2009 Sep 2;28(17):2541-53
pubmed: 19680228
J Virol. 2004 Jul;78(13):6709-14
pubmed: 15194745
J Virol. 2006 Nov;80(22):11040-54
pubmed: 16956943
Virology. 2011 Sep 1;417(2):385-93
pubmed: 21777931
Mol Cell. 2004 Nov 5;16(3):319-30
pubmed: 15525506
Mol Ther. 2006 Sep;14(3):316-27
pubmed: 16824801
Mol Ther. 2014 Mar;22(3):554-566
pubmed: 24100640
Trends Cell Biol. 2004 Oct;14(10):547-56
pubmed: 15450977
Virus Res. 2009 Nov;145(2):312-20
pubmed: 19682510
J Trop Pediatr. 2021 Aug 27;67(4):
pubmed: 34545404
Nat Rev Genet. 2012 Dec;13(12):840-52
pubmed: 23090257
J Virol. 2002 May;76(9):4401-11
pubmed: 11932407
Nat Rev Mol Cell Biol. 2007 Mar;8(3):195-208
pubmed: 17287812
Traffic. 2005 Mar;6(3):173-86
pubmed: 15702986

Auteurs

Jiuming Shi (J)

College of Life Sciences, Jilin Agricultural University, Changchun, 130118, Jilin Province, China.

Yifeng Pei (Y)

College of Life Sciences, Jilin Agricultural University, Changchun, 130118, Jilin Province, China.

Qian Yu (Q)

College of Life Sciences, Jilin Agricultural University, Changchun, 130118, Jilin Province, China.

Hao Dong (H)

College of Life Sciences, Jilin Agricultural University, Changchun, 130118, Jilin Province, China. donghao@jlau.edu.cn.
Engineering Research Center of Bioreactor and Pharmaceutical Development, Jilin Agricultural University, Changchun, 130118, China. donghao@jlau.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH